Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Paclitaxel and Cisplatin in Previously Untreated, Unresectable Invasive Thymoma or Thymic Carcinoma

NCT00818090 is registered in ClinicalTrials.gov with Korean Cancer Study Group as lead sponsor.

NCT NCT00818090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00818090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Paclitaxel and Cisplatin in Previously Untreated, Unresectable Invasive Thymoma or Thymic Carcinoma
Lead sponsor
Korean Cancer Study Group
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2008
Completion date
November 30, 2011
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thymic carcinoma, thymoma